BDNF impacts many neurotransmitters related to mental disorders (Gratacòs et al., 2007; Hyman et al., 1991), thus, it is not surprising that the BDNF Val66Met polymorphism has been recognized as a potential biomarker for many psychiatric disorders (Gratacòs et al., 2007). This evidence concerns the gene BDNF and psychiatric disorder.